| 摘要 |
The invention relates to pharmaceuticals for the prophylaxis, suppression, or elimination of allergic reactions in humans, wherein probiotic, gram-positive bacteria, such as Lactobacillus and Bifidobacterium are present as the substantial effective ingredient, namely as viable bacteria and/or inactivated bacteria and/or the genomic DNA thereof.
|
